Sanofi Ventures
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
- USA
- France
- United Kingdom
- Israel
- Denmark
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
Industries
- Fintech
- AI
- Blockchain
- Web3
About
Sanofi Ventures is the strategic investment arm of Sanofi, dedicated to fostering innovation in the healthcare sector by focusing on early-stage biotech and digital health companies. By partnering with top-tier entrepreneurs, Sanofi Ventures aims to catalyze advancements that enhance human health and reshape the healthcare landscape. The organization leverages Sanofi's extensive industry expertise and resources to support the development of groundbreaking solutions that address critical health challenges worldwide. Through strategic investments, Sanofi Ventures is committed to driving transformative change in healthcare delivery and patient outcomes.
Sanofi Ventures is the strategic investment arm of Sanofi, dedicated to fostering innovation in the healthcare sector by focusing on early-stage biotech and digital health companies. By partnering with top-tier entrepreneurs, Sanofi Ventures aims to catalyze advancements that enhance human health and reshape the healthcare landscape. The organization leverages Sanofi's extensive industry expertise and resources to support the development of groundbreaking solutions that address critical health challenges worldwide. Through strategic investments, Sanofi Ventures is committed to driving transformative change in healthcare delivery and patient outcomes.
Investment Thesis
Sanofi Ventures strategically invests in early stage biotech and digital health companies that focus on improving human health and transforming the practice of medicine. They serve as an entry point to the innovation ecosystem for Sanofi, strategically investing in early stage transformational science and technology, when companies are too early to partner with or acquire.
Manager's Experience
With a proven track record in venture capital, the fund manager has led investments primarily in the biopharmaceutical and enzyme technology sectors. Their expertise spans across North America and Europe, having successfully executed over 25 deals. Noteworthy exits include partnerships with leading healthcare companies, demonstrating a strong operator-first approach. The focus on early to growth-stage investments underscores a strategic commitment to leveraging data-driven insights for portfolio optimization.
Sanofi Ventures Contacts Information
Primary contact